Related Experiment Videos
[Treatment of urinary tract infections]
1Département de Pédiatrie, Centre Hospitalier Regional Universitaire, Grenoble.
Insights
Pediatric urinary tract infections (UTIs) require prompt evaluation for malformations. Treatment varies by infection site, severity, and patient age, often involving specific antibiotics for effective renal parenchyma sterilization.
Area of Science:
- Pediatrics
- Infectious Diseases
- Nephrology
Context:
- Urinary tract infections (UTIs) are prevalent in children and can lead to significant renal damage.
- UTIs may be the initial indicator of underlying urinary tract malformations, necessitating routine morphological assessments.
- Accurate diagnosis and management are crucial to prevent long-term complications.
Purpose:
- To outline diagnostic and therapeutic strategies for pediatric urinary tract infections.
- To emphasize the importance of evaluating urinary tract morphology in children with UTIs.
- To guide the selection of appropriate antimicrobial therapy based on clinical and microbiological factors.
Summary:
- Treatment selection for pediatric UTIs depends on causative organisms, infection location (distal vs. proximal urinary tract), symptom severity, patient age, and prior urologic history.
- Pyelonephritis treatment necessitates bactericidal agents for rapid renal parenchyma sterilization, with third-generation cephalosporins and aminoglycosides showing efficacy in animal studies.
- Therapy recommendations vary: parenteral cephalosporins and aminoglycosides for infants (<18 months) or severely ill patients; oral antibiotics (cephalosporin, amoxicillin-clavulanate, cotrimoxazole) for older, less ill children.
- Treatment duration differs: 10 days for proximal UTIs, 5–7 days for cystitis with normal urinary tract morphology.
Impact:
- Optimized treatment protocols can minimize the risk of permanent renal damage from pediatric UTIs.
- Early detection of urinary tract malformations through routine evaluation can prevent severe sequelae.
- Tailored antibiotic selection and duration improve patient outcomes and reduce antimicrobial resistance.
Abstract:
Urinary tract infection (UTI) is common in pediatric age groups and may cause permanent renal damage. Because UTI may occur as the first manifestation of urinary tract malformation, evaluation, of urinary tract morphology should be routine. Variables influencing selection of the most appropriate therapy include the causative organism, location of the infection to the distal and/or proximal urinary tract, severity of constitutional symptoms, age, and history for prior urologic disease. Treatment of pyelonephritis requires bactericidal antimicrobial agents capable of achieving rapid sterilization of the renal parenchyma. Animal experiments have shown that the most effective agents are third-generation cephalosporins and aminoglycosides. Antibiotics are selected on the basis of age and severity of infectious symptoms. In infants under 18 months of age and in patients with severe constitutional symptoms, parenteral administration of both a third-generation cephalosporin and an aminoglycoside is recommended. Patients above 18 months of age who are not severely ill can be given a single oral drug, e.g., a cephalosporin, amoxicillin with clavulanic acid, or cotrimoxazole. Therapy should be continued for ten days in patients with infection of the proximal urinary tract, whereas 5 to 7 days are adequate in patients with cystitis and normal urinary tract morphology.